Here, we found that miR-1296-5p was decreased in ERBB2-positive breast cancer samples when compared to ERBB2-negative breast cancer samples, suggesting that miR-1296-5p might be a tumor-suppressor gene in ERBB2-positive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.